Astera Labs (NASDAQ:ALAB) Stock Picked Up by Analysts at BMO Capital Markets

Analysts at BMO Capital Markets began coverage on shares of Astera Labs (NASDAQ:ALAB) in a note issued to investors on Thursday, Marketbeat reports. The brokerage set an “outperform” rating and a $375.00 price target on the stock. BMO Capital Markets‘s target price would suggest a potential upside of 96.63% from the company’s current price.

Several other research analysts also recently issued reports on ALAB. UBS Group reduced their price target on shares of Astera Labs from $300.00 to $290.00 and set a “neutral” rating on the stock in a research report on Wednesday. Royal Bank Of Canada lowered their price objective on shares of Astera Labs from $500.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday. Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Friday, October 9th. Roth Capital reiterated a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Weiss Ratings cut shares of Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research note on Friday, October 23rd. Thirteen equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $320.85.

Astera Labs Stock Up 6.3%

ALAB stock traded up $11.24 during midday trading on Thursday, reaching $190.71. 6,642,738 shares of the company’s stock traded hands, compared to its average volume of 4,244,483. The company has a 50-day simple moving average of $300.46 and a two-hundred day simple moving average of $255.80. Astera Labs has a 1-year low of $97.89 and a 1-year high of $499.48. The company has a market cap of $33.09 billion, a price-to-earnings ratio of 75.98 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.13. The company had revenue of $584.90 million for the quarter, compared to analyst estimates of $550.78 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The business’s revenue was up 153.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.49 earnings per share. Equities research analysts forecast that Astera Labs will post 2.71 EPS for the current year.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. This represents a 6.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 396,059 shares of company stock valued at $123,408,470 over the last 90 days. Corporate insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

A number of institutional investors and hedge funds have recently modified their holdings of the business. Diversified Trust Co raised its position in shares of Astera Labs by 303.8% during the 3rd quarter. Diversified Trust Co now owns 2,100 shares of the company’s stock valued at $748,000 after acquiring an additional 1,580 shares during the last quarter. Allworth Financial LP boosted its position in shares of Astera Labs by 4.9% in the 3rd quarter. Allworth Financial LP now owns 2,770 shares of the company’s stock worth $986,000 after purchasing an additional 129 shares during the last quarter. Private Advisory Group LLC bought a new position in shares of Astera Labs in the 3rd quarter worth $971,000. Russell Investments Group Ltd. grew its stake in shares of Astera Labs by 9.1% during the third quarter. Russell Investments Group Ltd. now owns 155,991 shares of the company’s stock worth $55,540,000 after purchasing an additional 13,004 shares during the period. Finally, Eurizon Capital SGR S.p.A. grew its stake in shares of Astera Labs by 26.4% during the third quarter. Eurizon Capital SGR S.p.A. now owns 58,220 shares of the company’s stock worth $20,725,000 after purchasing an additional 12,144 shares during the period. 60.47% of the stock is owned by institutional investors.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported Q3 revenue of $584.9 million, up 154% year over year, and its Scorpio switch business was highlighted as a major growth driver. One Seeking Alpha contributor upgraded the stock, citing Scorpio’s momentum and gross margins that may stabilize near 72%. Astera Labs: So Much To Like In Q3 (Upgrade)
• Positive Sentiment: BMO Capital initiated coverage with an Outperform rating and a $375 price target; Northland Securities also upgraded the stock to Outperform. These calls provide a counterpoint to recent selling and valuation worries. BMO Capital Initiates Coverage on Astera Labs With Outperform Rating Astera Labs Upgraded to Outperform at Northland Securities
• Neutral Sentiment: Analyst views remain divided, with one recent opinion arguing that the selloff may already reflect a potential growth slowdown in 2027. Astera Labs: Sell-Off Already Priced In 2027 Stall
• Negative Sentiment: A reported analyst downgrade triggered renewed pressure, while coverage also points to ALAB’s rich valuation after its Q3 results. Those concerns may amplify selling when technology stocks are broadly weak. Shares Gap Down After Analyst Downgrade Stock Drops After Q3 Results Spotlight Rich Valuation
• Negative Sentiment: Astera Labs was caught in a wider technology-sector selloff, adding market-wide pressure beyond company-specific news. Astera Labs Falls Amid Tech Selloff

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems.

The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Founded in 2017 and headquartered in Santa Clara, California, Astera Labs serves the global cloud and computing markets.